AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Fulvestrant in South Africa
9 products registered with SAHPRA — 9 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| FULVESTRANT SANDOZ | 56/21.12/0415 | Sandoz South Africa (Pty) Ltd | active | 2 Jul 2029 |
| FUVISTRA | 56/21.12/0245 | Ranbaxy Pharmaceutical (Pty) Ltd | active | 25 Jun 2029 |
| ACTIFULVE POWDER FOR SOLUTION FOR INJECTION AND ACTIFULVE DILUENT FOR SOLUTION FOR INJECTION | 56/21.12/0716 | Activo Health (Pty) Ltd | active | 7 May 2029 |
| VESOTA | 56/26/0406.405 | Aurogen South Africa (Pty) Ltd | active | 3 Oct 2028 |
| DESOFAL | 56/26/0405 | Aurogen South Africa (Pty) Ltd | active | 3 Oct 2028 |
| FULVEDEX 250 mg/5 ml | 55/21.12/0531 | Juno Pharma SA (Pty) Ltd | active | 8 Nov 2027 |
| FULDEXA | 55/21.12/0762 | Accord Healthcare (Pty) Ltd | active | 1 Nov 2027 |
| FASLODEX | A38/21.12/0656 | AstraZeneca Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
| FREXIVO | 56/21.12/0606 | AstraZeneca Pharmaceuticals (Pty) Ltd | active | 1 Jan 1900 |
Fulvestrant — SAHPRA Registration Details
SAHPRA (South Africa) has 9 registered products containing Fulvestrant, of which 9 are currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Fulvestrant registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.